Related Experiment Video

Updated: Aug 7, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[Prevention and treatment of congestive heart failure in diabetic patients]

Manuel Anguita Sánchez1

  • 1Servicio de Cardiología. Hospital Reina Sofía. Córdoba. España.

Revista Espanola De Cardiologia
|October 18, 2002
PubMed

Insights

Diabetes mellitus significantly increases cardiovascular disease risk and worsens outcomes. While the exact causes of higher heart failure rates in diabetics are debated, treatments remain similar, with new drug classes showing promise.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a major risk factor for cardiovascular disease (CVD).
  • Diabetic patients exhibit a higher incidence and severity of congestive heart failure (CHF).
  • The etiology of increased CHF in diabetes is multifactorial, potentially involving comorbidities or a distinct diabetic cardiomyopathy.

Purpose of the Study:

  • To explore the relationship between diabetes mellitus and cardiovascular disease, particularly heart failure.
  • To discuss the debated reasons for increased heart failure incidence in diabetic individuals.
  • To review current and emerging treatment strategies for heart failure in the context of diabetes.

Main Methods:

  • Literature review of studies on diabetes, cardiovascular disease, and heart failure.
  • Analysis of risk factors, including coronary heart disease and arterial hypertension.
  • Examination of treatment protocols for heart failure in diabetic versus non-diabetic patients.

Main Results:

  • Diabetes is confirmed as a significant risk factor for CVD and poorer prognosis.
  • The elevated rate of heart failure in diabetics is attributed to factors like severe coronary heart disease, hypertension, or diabetic cardiomyopathy.
  • Standard heart failure treatments are applicable, with emerging research on ACE inhibitors and ARBs.

Conclusions:

  • Diabetes mellitus necessitates careful cardiovascular risk management.
  • Further research is needed to elucidate the specific mechanisms of diabetic cardiomyopathy.
  • Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers represent a promising therapeutic avenue for heart failure in diabetic patients.

More Related Videos

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...